CMS Entry id: 2710 | Channel: News landing page | Template: news/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

News

24 November 2022

Cambridge Cognition unveils strategic partnership for Chinese market expansion

Cambridge Cognition is pleased to announce an expansion in the Chinese market through a strategic partnership with Luca Healthcare Limited, a category leader in digital screening, treatment and management tools in China.  Cambridge Cognition has signed an exclusive licencing agreement with Luca Healthcare to commercialise the Company’s suite of leading cognitive assessment tools in China for both the pharmaceutical and healthcare markets.


12 October 2022

Cambridge Cognition strengthens virtual clinical trials offering with eClinicalHealth acquisition

Cambridge Cognition has entered an agreement to acquire eClinicalHealth Ltd; a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.

17 August 2022

Cambridge Cognition selected by the University of Oxford as a cognitive assessment partner for the ISAP study

Alzheimer's disease validation for NeuroVocalixTM

28 July 2022

CANTAB to be used in US Department of Defense PTSD trial

We are pleased to announce two agreements in a new therapeutic area for Cambridge Cognition, post-traumatic stress disorder ("PTSD").  Most recently, a research agreement was entered into with the United States Department of Defense, following on from a contract secured earlier this year with a top 10 pharmaceutical company.  

18 July 2022

Join us at AAIC 2022

We are looking forward to attending this year’s Alzheimer’s Association International Conference (AAIC) in San Diego from 31st July to 4th August and learning about the latest developments in dementia research.

14 July 2022

2022 CANTAB Research Grant winners announced

It has been another highly competitive year for our CANTABTM Research Grant, with the large number of high-quality applications making picking just three winners a challenge for our judging panel! Here we reveal the winning grants.

31 May 2022

Cambridge Cognition partners on ambitious project for digital measurement of Alzheimer’s disease and related dementia symptoms

Cambridge Cognition is pleased to announce that they have joined the Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias (ADRD) Digital Measure Development project. As a partner of this innovative, collaborative effort, Cambridge Cognition will work to harness the potential of digital medicine to advance therapies for ADRD.